Insight

Jul 9, 2024, 03:14

Naveen Pemmaraju: MPN AYA state-of-the-art review

Naveen Pemmaraju shared a post on X:

“MPN AYA state-of-the-art review led by Hannah Goulart and Naveen Pemmaraju.”

Naveen Pemmaraju

Source: Naveen Pemmaraju/X

Myeloproliferative neoplasms in the adolescent and young adult population: A comprehensive review of literature.

Authors: Hannah Goulart, Lucia Masarova, Ruben Mesa, Claire Harrison, Jean-Jacques Kiladjian and Naveen Pemmaraju.

Naveen Pemmaraju is a Professor and Director of BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center (MDACC) and Executive Director of MDACC Network. He is also the Leukemia Hematology/Oncology Course Director.

His research work has been focused on improving outcomes and developing novel therapies for patients with rare, and ultra-rare, myeloid malignancies; including adolescents, young adults, and older adult patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), MPN and AML.

cancer Claire Harrison Hannah Goulart Jean-Jacques Kiladjian Lucia Masarova MD Anderson Cancer Center MDACC myeloproliferative neoplasms Naveen Pemmaraju OncoDaily Oncology Ruben Mesa

Mark Ruffalo and Brain Cancer: How He Went Against, How He Survived, and More

Sharon Osbourne and Colon Cancer: How She Went Against, How She Survived, and More

Marcia Cross and Anal Cancer: How She Went Against, How She Survived, and More

Pancreatic Cancer: Symptoms, Causes, Types, Diagnosis & Treatment

FDA approves Methotrexate for Pediatric acute Lymphoblastic Leukemia

Special Coverage